Jazz Pharmaceuticals gets US FDA approval of Xywav for cataplexy associated with narcolepsy

Jazz Pharmaceuticals gets US FDA approval of Xywav for cataplexy associated with narcolepsy. (Credit: PRNewsfoto/Jazz Pharmaceuticals plc)